Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.4c16129 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Zamira V Díaz-Riascos und 23 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT), Vall d'Hebron Institute of Research (VHIR), 08035 Barcelona, Spain. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Magnetite Nanoparticles, Hyperthermia, Induced, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Generalitat de Catalunya, Seventh Framework Programme.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT), Vall d'Hebron Institute of Research (VHIR), 08035 Barcelona, Spain.
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08035 Barcelona, Spain.
- Functional Validation & Preclinical Research (FVPR), Unit20 ICTS Nanbiosis, Vall d'Hebron Institute of Research (VHIR), 08035 Barcelona, Spain.
- IMDEA Nanociencia, Unidad Asociada al Centro Nacional de Biotecnología (CSIC) 28049 Madrid, Spain.
- Nanomedicine and Molecular Imaging group, Trinity Translational Medicine Institute (TTMI), Trinity College Dublin (TCD), Dublin 8 Dublin, Ireland.
- Laboratoire Matière et Systèmes Complexes (MSC), UMR 7057 CNRS, Université Paris Diderot, Paris 75205, cedex, France.
ORCID-Profile: Francisco J Terán, Gorka Salas, Adriele Prina-Mello, Florence Gazeau, Álvaro Somoza, Simó Schwartz, Ibane Abasolo
Förderung
- Ministerio de Ciencia, Innovación y Universidades
- Generalitat de Catalunya
- Seventh Framework Programme
Zitieren
APA
Díaz-Riascos, Z. V., Llaguno-Munive, M., Lafuente-Gómez, N., Luengo, Y., Holmes, S., Volatron, J., Ibarrola, O., Mancilla, S., Sarno, F., Aguirre, J. J., Razafindrakoto, S., Southern, P., Terán, F. J., Keogh, A., Salas, G., Prina-Mello, A., Lacal, J. C., Del Pozo, A., Pankhurst, Q. A., …, & Abasolo, I. (2025). Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c16129
Vancouver
Díaz-Riascos ZV, Llaguno-Munive M, Lafuente-Gómez N, Luengo Y, Holmes S, Volatron J, et al. Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c16129
BibTeX
@article{DazRiascos2025,
author = {Díaz-Riascos, Zamira V and Llaguno-Munive, Monserrat and Lafuente-Gómez, Nuria and Luengo, Yurena and Holmes, Sarah and Volatron, Jeanne and Ibarrola, Oihane and Mancilla, Sandra and Sarno, Francesca and Aguirre, José Javier and Razafindrakoto, Sarah and Southern, Paul and Terán, Francisco J and Keogh, Anna and Salas, Gorka and Prina-Mello, Adriele and Lacal, Juan Carlos and Del Pozo, Angel and Pankhurst, Quentin A and Hidalgo, Manuel and Gazeau, Florence and Somoza, Álvaro and Schwartz, Simó and Abasolo, Ibane},
title = {Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.4c16129}
}
EUVIMED